Company / Capital Expenditures
HealthEquity Capital Expenditures History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.7M
FY2026
5-year range
$1.7M / $7.3M
FY2022-FY2026
Trend
-14.0%
vs FY2025
Sector context
#143 of 151
Health Care
What the data says
Among 151 Health Care companies, HealthEquity is in the bottom 5% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2026 to $13M in FY2020.
Based on SEC 10-K filings.
$2M in FY2026 with a 5-year CAGR of -15.2%.
Declined from $2M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 151This company $1.7M Sector average $271.7M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -15.2%, indicating a declining trend.
- In FY2026, capital expenditures decreased 14.0% year-over-year.
- Ranks #143 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.7M | -14.0% |
| FY2025 | $2.0M | -5.5% |
| FY2024 | $2.1M | +23.0% |
| FY2023 | $1.7M | -76.7% |
| FY2022 | $7.3M | +88.3% |
| FY2021 | $3.9M | -70.4% |
| FY2020 | $13.1M | +79.7% |
| FY2019 | $7.3M | +88.3% |
| FY2018 | $3.9M | -29.1% |
| FY2017 | $5.5M | +49.7% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026